In a landmark validation study, researchers at the Mayo Clinic have developed an AI tool that can detect signs of pancreatic cancer up to three years before a diagnosis is typically made. This innovative technology is capable of identifying pancreatic ductal adenocarcinoma at an early stage, even spotting changes that are often invisible to standard detection methods. The AI model has demonstrated a higher accuracy in recognizing early signs of the disease compared to human radiologists, paving the way for significant advancements in early cancer detection. This breakthrough could help doctors identify patients at risk long before symptoms manifest, revolutionizing the approach to a notoriously difficult-to-detect cancer.